SeaStar Medical is trading at $3.08, up 6.20% in live trading, with no clear company-specific catalyst identified for the October 19 move.
- The latest identified company news was an October 14 award announcement, which does not establish a direct catalyst for the gain.
- Healthcare was reported as a leading sector amid investor rotation toward defensive shares; this is sector context, not confirmation of the cause of SeaStar Medical’s move.